Keywords
Papillomavirus Human
prevalence
sedentary lifestyle
overweight
obesity
How to Cite
Abstract
Introduction: Infection with Human Papillomavirus is mandatory for cervical cancer development. However, viral elimination is associated to multiple factors, according to the population characteristics and geographic areas, some are modifiable and others not. Objective: To determine the factors associated with the prevalence of high risk human papillomavirus infection in women between 35-65 years old with moderate or high risk of cervical cancer located at the northern zone of Bucaramanga Methodology: Cross-sectional analytical study. Women classified as moderate/ high risk for cervical cancer in a short standardized survey, were surveyed on the side effects associated to chronic viral infection and self-sampling cervical test. Bivariate analysis and multiple analysis of log-binomial regression were performed. Results: 810 women were interviewed; 435 cases of high cancer risk were presented. The prevalence of high risk human papilloma virus infection was 5.1% (95% CI 3.2-7.6). The sedentary lifestyle (RPa 2.51, 95% CI 1.15-5.50) and overweight/obesity (PRa 4.20, 95% CI 1.00-15.51) were associated with higher prevalence. In addition, there was a trend of increased prevalence of infection among users of injectable contraceptives; as well as a tendency to decrease this prevalence according to portions of fruits and vegetables consumed daily. Conclusion: modifiable factors such as sedentary lifestyle and overweight / obesity were independently associated with a higher prevalence of infection by human high risk papilloma virus in the population studied.
References
2. Longworth MS, Laimins LA. Pathogenesis of Human Papillomaviruses in differentiating epithelia. Microbiol Mol Biol Rev. 2004; 68(2): 362-372. doi: 10.1128/MMBR.68.2.362-372.2004.
3. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase. International Agency for Research on Cancer. 2013; (11).
4. Arbyn M, Castellsagué X, de Sanjosé S, Bruni L, Saraiya M, Bray F, et al. Worldwide burden of cervical cancer in 2008. Ann Oncol. 2011; 22(12): 2675-2686. doi: 10.1093/annonc/mdr015.
5. de Martel C, Plummer M, Vignat J, Franceschi S. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017; 141(4): 664-670. doi: 10.1002/ijc.30716.
6. Ribeiro AA, Costa MC, Alves RRF, Villa LL, Saddi VA, Carneiro MADS, et al. HPV infection and cervical neoplasia: Associated risk factors. Infect Agent Cancer. 2015; 10(1). doi: 10.1186/s13027-015-0011-3.
7. Hernandez BY, Wilkens LR, Zhu X, Thompson P, McDuffie K, Shvetsov YB, et al. Transmission of human papillomavirus in heterosexual couples. Emerg Infect Dis. 2008; 14(6): 888-894. doi: 10.3201/eid1406.070616.2.
8. Vielot N, Hudgens MG, Mugo N, Chitwa M, Kimani J, Smith J. The role of chlamydia trachomatis in high-risk human papillomavirus persistence among female sex workers in Nairobi, Kenya. Sex Transm Dis. 2015; 42(6): 305-311. doi: 10.1097/OLQ.0000000000000287.
9. Hwang LY, Ma Y, Benningfield SM, Clayton L, Hanson EN, Jay J, et al. Factors that influence the rate of epithelial maturation in the cervix in healthy young women. J. Adolesc Heal. 2009; 44(2): 103-110. doi: 10.1016/j.jadohealth.2008.10.006.
10. Stensen S, Kjaer SK, Jensen SM, Frederiksen K, Junge J, Iftner T, et al. Factors associated with type-specific persistence of high-risk human papillomavirus infection: A population-based study. Int J Cancer. 2016; 138(2): 361-368. doi: 10.1002/ijc.29719.
11. Obiri YD, Adu SY, Djigma F, Hayfron B, Abdul L, Simpore J, Mayaud, P, et al. Self-collected vaginal sampling for the detection of genital human papillomavirus (HPV) using care HPV among Ghanaian women. BMC women's health. 2017; 17(1), 86. doi: 10.1186/s12905-017-0448-1.
12. Gupta SP, Bik EM, Cardenas JP, Nuñez H, Kraal L, Goddard AD, et al. Self-sampling for human papillomavirus testing: increased cervical cancer screening participation and incorporation in international screening programs. Front Public Health. 2018; 6: 77. doi: 10.3389/fpubh.2018.00077.
13. Ketelaars PJ, Bosgraaf RP, Siebers AG, Massuger LG, Van der Linden JC, Wauters CA, et al. High-risk human papillomavirus detection in self-sampling compared to physician-taken smear in a responder population of the Dutch cervical screening: results of the VERA study. Prev Med. 2017; 101: 96-101. doi: 10.1016/j.ypmed.2017.05.021.
14. Jentschke M, Chen K, Arbyn M, Hertel B, Noskowicz M, Soergel P, et al. Direct comparison of two vaginal self-sampling devices for the detection of human papillomavirus infections. J Clin Virol. 2016; 82: 46-50. doi: 10.1016/j.jcv.2016.06.016.
15. Herraez-Hernandez E, Alvarez-Perez M, Navarro-Bustos G, Esquivias J, Alonso S, Aneiros-Fernandez J, et al. HPV Direct Flow CHIP: A new human papillomavirus genotyping method based on direct PCR from crude-cell extracts. J Virol Methods. 2013; 193(1) :9-17. doi: 10.1016/j.jviromet.2013.04.018.
16. Eklund CF, Forslund O, Wallin KL, Dillner J. Global improvement in genotyping of human papillomavirus DNA: the 2011 HPV LabNet International Proficiency Study. J Clin Microbiol. 2014; 52(2); 449-459. doi: 10.1128/JCM.02453-13.
17. 2008 Physical activity guidelines advisory committee. Physical activity guidelines advisory committee report. Washington DC: US. 2008; 67(2): 683.
18. Molano M, Posso H, Weiderpass E, Van den Brule AJC, Ronderos M, Franceschi S, et al. Prevalence and determinants of HPV infection among Colombian women with normal cytology. Br J Cancer. 2002; 87(3): 324-333. doi: 10.1038/sj.bjc.6600442.
19. Giuliano AR, Papenfuss M, Schneider A, Nour M, Hatch K. Risk factors for high-risk type human papillomavirus infection among Mexican-American women. Cancer Epidemiol Biomarkers Prev. 1999; 8(7): 615-620.
20. Molano M, Van den Brule A, Plummer M, Weiderpass E, Posso H, Arslan A, et al. Determinants of clearance of human papillomavirus infections in Colombian women with normal cytology: A population-based, 5-year follow-up study. Am J Epidemiol. 2003; 158(5): 486-494.
21. Bedoya AM, Gaviria AM, Baena A, Borrero M, Duarte DF, Combita AL, et al. Age-specific seroprevalence of human papillomavirus 16, 18, 31, and 58 in women of a rural town of Colombia. Int J Gynecol Cancer. 2012; 22(2): 303-310. doi: 10.1097/IGC.0b013e31823c2469.
22. Quinónez-Calvache EM, Ríos-Chaparro DI, Ramírez JD, Soto-De León SC, Camargo M, Río-Ospina L Del, et al. Chlamydia trachomatis Frequency in a Cohort of HPV-infected Colombian women. PLoS One. 2016; 11(1). doi: 10.1371/journal.pone.0147504.
23. Appleby P, Beral V, Berrington de González A, Colin D, Franceschi S, Goodill A, et al. Carcinoma of the cervix and tobacco smoking: Collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. Int J Cancer. 2006; 118(6): 1481-1495. doi: 10.1002/ijc.21493.
24. Giuliano AR, Harris R, Sedjo RL, Baldwin S, Roe D, Papenfuss MR, et al. Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Women’s
Health Study. J Infect Dis. 2002; 186(4): 462-469. doi: 10.1086/341782.
25. Lee JK, So KA, Piyathilake CJ, Kim MK. Mild Obesity, Physical Activity, Calorie intake, and the risks of cervical intraepithelial neoplasia and cervical cancer. PLoS One. 2013; 8(6). doi: 10.1371/journal.pone.0066555.
This work is licensed under a Creative Commons Attribution 4.0 International License.